Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

A link between p73 transcriptional activity and p73 degradation.

Wu L, Zhu H, Nie L, Maki CG.

Oncogene. 2004 May 13;23(22):4032-6.

PMID:
15021899
2.

Transactivation-dependent and -independent regulation of p73 stability.

Dulloo I, Sabapathy K.

J Biol Chem. 2005 Aug 5;280(31):28203-14. Epub 2005 May 26.

3.

p73 transcriptional activity increases upon cooperation between its spliced forms.

Alarcon-Vargas D, Fuchs SY, Deb S, Ronai Z.

Oncogene. 2000 Feb 10;19(6):831-5.

4.

A possible role of p73 on the modulation of p53 level through MDM2.

Wang XQ, Ongkeko WM, Lau AW, Leung KM, Poon RY.

Cancer Res. 2001 Feb 15;61(4):1598-603.

5.

p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop.

Kartasheva NN, Contente A, Lenz-Stöppler C, Roth J, Dobbelstein M.

Oncogene. 2002 Jul 18;21(31):4715-27.

6.

TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.

Malaguarnera R, Vella V, Pandini G, Sanfilippo M, Pezzino V, Vigneri R, Frasca F.

Mol Cancer Res. 2008 Jan;6(1):64-77. doi: 10.1158/1541-7786.MCR-07-0005.

7.

Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.

Muttray AF, Cox RL, Reinisch CL, Baldwin SA.

Mar Biotechnol (NY). 2007 Mar-Apr;9(2):217-30. Epub 2007 Jan 22.

PMID:
17242983
8.

Mdm2 binds p73 alpha without targeting degradation.

Bálint E, Bates S, Vousden KH.

Oncogene. 1999 Jul 8;18(27):3923-9.

9.

p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade.

Nozaki M, Tada M, Kashiwazaki H, Hamou MF, Diserens AC, Shinohe Y, Sawamura Y, Iwasaki Y, de Tribolet N, Hegi ME.

Brain Pathol. 2001 Jul;11(3):296-305.

PMID:
11414472
10.
11.

DNA-binding and transactivation activities are essential for TAp63 protein degradation.

Ying H, Chang DL, Zheng H, McKeon F, Xiao ZX.

Mol Cell Biol. 2005 Jul;25(14):6154-64.

12.

MDM2 and MDMX can interact differently with ARF and members of the p53 family.

Wang X, Arooz T, Siu WY, Chiu CH, Lau A, Yamashita K, Poon RY.

FEBS Lett. 2001 Feb 16;490(3):202-8.

13.

Differential modulation of cellular and viral promoters by p73 and p53.

Deb D, Lanyi A, Scian M, Keiger J, Brown DR, Le Roith D, Deb SP, Deb S.

Int J Oncol. 2001 Feb;18(2):401-9.

PMID:
11172610
14.
15.
16.

Subcellular distribution of p53 and p73 are differentially regulated by MDM2.

Gu J, Nie L, Kawai H, Yuan ZM.

Cancer Res. 2001 Sep 15;61(18):6703-7.

17.

The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.

Calabrò V, Mansueto G, Parisi T, Vivo M, Calogero RA, La Mantia G.

J Biol Chem. 2002 Jan 25;277(4):2674-81. Epub 2001 Nov 19.

18.

p73, a sophisticated p53 family member in the cancer world.

Ozaki T, Nakagawara A.

Cancer Sci. 2005 Nov;96(11):729-37. Review.

19.

Nuclear import and export signals in control of the p53-related protein p73.

Inoue T, Stuart J, Leno R, Maki CG.

J Biol Chem. 2002 Apr 26;277(17):15053-60. Epub 2002 Feb 14.

20.

Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.

Saifudeen Z, Diavolitsis V, Stefkova J, Dipp S, Fan H, El-Dahr SS.

J Biol Chem. 2005 Jun 17;280(24):23094-102. Epub 2005 Apr 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk